Opinion · 28 Dec 2024
CommentaryPublished 28 Jan 2022
T lymphocytes-based immunotherapy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Illusory Antigen Receptor T cell is a T lymphocyte-based immunotherapy, which accomplishes extraordinary triumphs in treating blood malignancies and gives new desire to sign progressed disease patients. Invariant Normal Executioner T (iNKT) cells are a sort of exceptional T lymphocytes portrayed by communicating invariant TCR of V24V11 to perceive CD1d-introduced glycolipid antigens, which span intrinsic and versatile invulnerable reactions. iNKT cells themselves show solid enemy of growth impact in cancer models by means of CD1d-intervened killing of CD1d-positive cancer cells and immunosuppressive TAMs and MDSCs, and are firmly connected with the guess of disease patients. iNKT cells are not confined to Polymorphic Human Leukocyte Antigen (HLA) and can forestall Graft Versus Host Disease (GvHD), which comes to be an optimal CAR vector for allogeneic treatment. In this survey, we summed up the current status of clinical use of iNKT cells and the most recent accomplishments of CAR-iNKT cells, which gives new understanding in CAR-iNKT advancement and uses.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 28 Sep 2015
Chemokine receptors in cytotoxic T-lymphocyte trafficking to tumors: Implications for immunotherapy
Short communication · 29 Nov 2024
Neoantigen Discovery and Dendritic Cell-based Vaccines in Lung Cancer Immunotherapy
Perspective · 30 Dec 2021
Cell-based Immunotherapies: Molecular Imaging Biomarkers
Conference abstract · 2018
Evidence-based practice for the sub-classification of nonsmall cell lung carcinoma (NSCLC) using current WHO criteria: moving from targeted therapy to immunotherapy
More from this journal
The newest in Journal of Molecular Cancer.
Article · 29 Apr 2024
Unveiling cancer: Mechanisms, progress and future directions
Article · 28 Apr 2024
Transcriptomics: Unraveling gene expression for advanced genomic insights
Article · 27 Apr 2024
Molecular mechanisms of cancer: Insights into tumor biology and therapeutic advances
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Molecular Cancer
- SubjectGenetics & Molecular Biology
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Cloe Emily”

